TearRestore Overview

  • Status
  • Private

  • Employees
  • 5

Employees

  • Latest Deal Type
  • Grant

  • Latest Deal Amount
  • $24.5K

  • Investors
  • 2

TearRestore General Information

Description

Operator of a med-tech company intended to provide patient-focused dry eye therapy and products. The company offers an open-eye thermal mask that utilizes reusable heat packs to warm the oil glands of the eyelids while not hindering the user's vision throughout treatment, and also provides cleansing wipes that relieve eye irritation, enabling patients to improve these irritants by developing easy-to-implement treatment routines.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Angel-Backed
Corporate Office
  • 821 Douglas Avenue
  • Minneapolis, MN 55403
  • United States
+1 (612)
Primary Industry
Medical Supplies
Other Industries
Therapeutic Devices
Personal Products
Corporate Office
  • 821 Douglas Avenue
  • Minneapolis, MN 55403
  • United States
+1 (612)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

TearRestore Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Grant 10-Oct-2022 $24.5K Completed Generating Revenue
3. Grant 10-May-2021 Completed Generating Revenue
2. Angel (individual) 06-May-2020 $500K $500K Completed Generating Revenue
1. Grant 14-Mar-2017 $50K Completed Startup
To view TearRestore’s complete valuation and funding history, request access »

TearRestore Patents

TearRestore Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20250195411-A1 Eyelid dysfunction treatment serum Pending 19-Dec-2023
US-11190025-B2 Control apparatus, control method, and power storage control apparatus Active 16-May-2016
US-20190086891-A1 Control apparatus, control method, and power storage control apparatus Active 16-May-2016
US-11826279-B2 Eyelid treatment device and associated methods Active 08-Mar-2016
US-20190083301-A1 Eyelid treatment device and associated methods Active 08-Mar-2016 A61F7/034
To view TearRestore’s complete patent history, request access »

TearRestore Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

TearRestore Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds
Launch Minnesota Government
US National Science Foundation Accelerator/Incubator
To view TearRestore’s complete investors history, request access »

TearRestore FAQs

  • Where is TearRestore headquartered?

    TearRestore is headquartered in Minneapolis, MN.

  • What is the size of TearRestore?

    TearRestore has 5 total employees.

  • What industry is TearRestore in?

    TearRestore’s primary industry is Medical Supplies.

  • Is TearRestore a private or public company?

    TearRestore is a Private company.

  • What is TearRestore’s current revenue?

    The current revenue for TearRestore is .

  • How much funding has TearRestore raised over time?

    TearRestore has raised $500K.

  • Who are TearRestore’s investors?

    Launch Minnesota and US National Science Foundation have invested in TearRestore.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process